• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中丝裂原活化蛋白激酶(MAPK)通路的建模:突变与靶向治疗

modelling of the mitogen-activated protein kinase (MAPK) pathway in colorectal cancer: mutations and targeted therapy.

作者信息

Sommariva Sara, Berra Silvia, Biddau Giorgia, Caviglia Giacomo, Benvenuto Federico, Piana Michele

机构信息

Methods for Image and Data Analysis Group, Dipartimento di Matematica, Università di Genova, Genova, Italy.

Life Science Computational Laboratory, Ospedale Policlinico San Martino IRCCS, Genova, Italy.

出版信息

Front Syst Biol. 2023 Aug 23;3:1207898. doi: 10.3389/fsysb.2023.1207898. eCollection 2023.

DOI:10.3389/fsysb.2023.1207898
PMID:40809474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12342002/
Abstract

Chemical reaction networks (CRNs) are powerful tools for describing the complex nature of cancer's onset, progression, and therapy. The main reason for their effectiveness is in the fact that these networks can be rather naturally encoded as a dynamical system whose asymptotic solution mimics the proteins' concentration profile at equilibrium. This paper relies on a complex CRN previously designed for modeling colorectal cells in their G1-S transition phase and presents a mathematical method to investigate global and local effects triggered on the network by partial and complete mutations occurring mainly in its mitogen-activated protein kinase (MAPK) pathway. Further, this same approach allowed the modeling and dosage of a multi-target therapeutic intervention that utilizes MAPK as its molecular target. Overall the results shown in this paper demonstrate how the proposed approach can be exploited as a tool for the in-silico comparison and evaluation of different targeted therapies. Future effort will be devoted to refine the model so to incorporate more biologically sound partial mutations and drug combinations.

摘要

化学反应网络(CRNs)是描述癌症发生、发展和治疗复杂本质的有力工具。其有效性的主要原因在于,这些网络可以相当自然地编码为一个动态系统,其渐近解模拟了平衡状态下蛋白质的浓度分布。本文基于先前设计的用于模拟处于G1-S转变阶段的结肠直肠细胞的复杂CRN,并提出了一种数学方法,以研究主要在其丝裂原活化蛋白激酶(MAPK)途径中发生的部分和完全突变对网络触发的全局和局部影响。此外,同样的方法还能对以MAPK为分子靶点的多靶点治疗干预进行建模和剂量计算。总体而言,本文所示结果证明了所提出的方法如何能够用作不同靶向治疗的计算机模拟比较和评估工具。未来的工作将致力于完善模型,以便纳入更多生物学上合理的部分突变和药物组合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/a28a88c4cdb6/fsysb-03-1207898-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/ccde5619792c/fsysb-03-1207898-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/28bb89b790bc/fsysb-03-1207898-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/ab22c3451770/fsysb-03-1207898-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/4122816f89b9/fsysb-03-1207898-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/f8031b309674/fsysb-03-1207898-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/f3a60679d633/fsysb-03-1207898-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/b332e320ef97/fsysb-03-1207898-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/a28a88c4cdb6/fsysb-03-1207898-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/ccde5619792c/fsysb-03-1207898-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/28bb89b790bc/fsysb-03-1207898-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/ab22c3451770/fsysb-03-1207898-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/4122816f89b9/fsysb-03-1207898-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/f8031b309674/fsysb-03-1207898-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/f3a60679d633/fsysb-03-1207898-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/b332e320ef97/fsysb-03-1207898-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8636/12342002/a28a88c4cdb6/fsysb-03-1207898-g008.jpg

相似文献

1
modelling of the mitogen-activated protein kinase (MAPK) pathway in colorectal cancer: mutations and targeted therapy.结直肠癌中丝裂原活化蛋白激酶(MAPK)通路的建模:突变与靶向治疗
Front Syst Biol. 2023 Aug 23;3:1207898. doi: 10.3389/fsysb.2023.1207898. eCollection 2023.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
The agreement of phonetic transcriptions between paediatric speech and language therapists transcribing a disordered speech sample.儿科言语和语言治疗师转写语音样本的音标转录的一致性。
Int J Lang Commun Disord. 2024 Sep-Oct;59(5):1981-1995. doi: 10.1111/1460-6984.13043. Epub 2024 Jun 8.
5
Short-Term Memory Impairment短期记忆障碍
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Electrophoresis电泳
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Rational combinations of targeted cancer therapies: background, advances and challenges.靶向癌症治疗的合理组合:背景、进展与挑战
Nat Rev Drug Discov. 2023 Mar;22(3):213-234. doi: 10.1038/s41573-022-00615-z. Epub 2022 Dec 12.
2
Increasing Incidence of Early-Onset Colorectal Cancer.早发性结直肠癌发病率上升。
N Engl J Med. 2022 Apr 21;386(16):1547-1558. doi: 10.1056/NEJMra2200869.
3
Early-onset colorectal cancer: Current insights and future directions.早发性结直肠癌:当前见解与未来方向
World J Gastrointest Oncol. 2022 Jan 15;14(1):230-241. doi: 10.4251/wjgo.v14.i1.230.
4
Can Systems Biology Advance Clinical Precision Oncology?系统生物学能否推动临床精准肿瘤学的发展?
Cancers (Basel). 2021 Dec 16;13(24):6312. doi: 10.3390/cancers13246312.
5
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.致癌性 KRAS 在结直肠癌的预后、诊断和治疗中的作用。
Mol Cancer. 2021 Nov 6;20(1):143. doi: 10.1186/s12943-021-01441-4.
6
ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.ERK:癌症的双刃剑。ERK 依赖性细胞凋亡作为癌症潜在的治疗策略。
Cells. 2021 Sep 22;10(10):2509. doi: 10.3390/cells10102509.
7
Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?生长因子、PI3K/AKT/mTOR和MAPK信号通路在结直肠癌发病机制中的作用:我们目前的进展如何?
Int J Mol Sci. 2021 Sep 23;22(19):10260. doi: 10.3390/ijms221910260.
8
Quantifying ERK activity in response to inhibition of the BRAFV600E-MEK-ERK cascade using mathematical modelling.使用数学模型量化响应BRAFV600E-MEK-ERK级联抑制的ERK活性。
Br J Cancer. 2021 Nov;125(11):1552-1560. doi: 10.1038/s41416-021-01565-w. Epub 2021 Oct 7.
9
Computational quantification of global effects induced by mutations and drugs in signaling networks of colorectal cancer cells.计算量化结直肠癌细胞信号网络中突变和药物引起的全局效应。
Sci Rep. 2021 Oct 1;11(1):19602. doi: 10.1038/s41598-021-99073-7.
10
Global colorectal cancer burden in 2020 and projections to 2040.2020年全球结直肠癌负担及到2040年的预测。
Transl Oncol. 2021 Oct;14(10):101174. doi: 10.1016/j.tranon.2021.101174. Epub 2021 Jul 6.